Skip to Main Content
Press Releases

Baker Donelson Represents S&S Health in Growth Investment from Lovell Minnick Partners

The national law firm of Baker Donelson advised S&S Health (S&S), a leading provider of administration and technology solutions for health plans for small and mid-sized businesses, in connection with a majority growth investment from Lovell Minnick Partners LLC (LMP), a private equity firm focused on investments in financial services, business services, and financial technology companies.

This strategic partnership will enable S&S to advance organic growth initiatives, enhance operational efficiency, and accelerate its mission to improve health care outcomes nationwide.

The Baker Donelson team was led by Corporate/M&A shareholders Joseph R. Delgado Jr. and Ryan M. Richards and Corporate/M&A associates John D. McCallister, Jackson Cates, Gabby Haddad, and Stefan R. Kostas.

The team also included Hunter Threet (Corporate/M&A), Steven K. Wood (Tax), Layna Cook Rush (Insurance Regulatory), Claude P. Czaja (Real Estate), Anthony C. Cianciotti (Finance), David Gevertz (Employment), Katherine I. Funk (Antitrust), Tyler Saenz (Corporate/M&A), Sarah Sexton (Corporate/M&A), Kareim Oliphant (Corporate/M&A), Jack Ritossa (Corporate/M&A), Carl Davis II (IP), J. Scott Newton (Litigation), and William E. Robinson (Employee Benefits).

S&S Health was founded in 1994 with a focus on comprehensive health care services and coverage. S&S Health's proprietary claims adjudication platform enables the company to support any plan design, level of complexity, and account structure to offer cost-effective, tailored solutions for employers. In addition to benefit plan administration, S&S provides employers with provider network access and a marketplace of solutions for wellness and cost-containment strategies.

Email Disclaimer

NOTICE: The mailing of this email is not intended to create, and receipt of it does not constitute an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.
Cancel Accept